‘Overall the industry has improved’
Asks Alan Lakey
‘Still one of the very best’
'A simple critical illness design'
Focus on adult conditions
Weighing up children's critical illness cover
Third L&G CI enhancement of 2018
Upgrades "reinforce Aviva's position as a market leader," says Alan Lakey
Alan Lakey is 'impressed by the two policies which offers flexibility to match individual needs' which 'compete strongly with other top quality policies'
Instead of 'deckchair shifting', the ABI should tidy up confusion around critical illness condition definitions
'Guardian's full-scale entry is bound to shake up the market,' says CIExpert
"Substantial improvements across the board," says Alan Lakey
Simplifications for heart attack, stroke and cancer (and more) with exclusions removed
Consolidation of "market-leading" position with better quality of choice and by mirroring Aviva's two-pronged approach to children's cover
New version is "a different beast entirely" compared to individual CIC plans, says Alan Lakey
"Any upgrade is welcome if the result is more claims paid," says CIExpert's Alan Lakey
CIExpert has analysed Friends Life's latest critical illness saying it has provided a 'riposte' to AIG's challenge to be the top CI provideer.
CIExpert has revealed that Aegon has made some substantial improvements to its critical illness cover which elevates it higher within the CIExpert comparative tables.
CIExpert has upgraded its website to allow advisers to make comparisons between new and existing policies when reviewing the merits of replacing a client's existing policy.
CIExpert has analysed the launch of Aviva's business protection policies and described its Relevant Life plan with integrated critical illness cover as a ‘breakthrough' for the protection market.
Alan Lakey highlights the reasons why he believes mortgage advisers tend to have difficulty in making the protection sale.
CIExpert said that AIG Life has ‘laid down a challenge to other providers with substantial enhancements to its critical illness plan.'
Advisers should take on board Financial Ombudsman decisions when making recommendations, writes Alan Lakey.